Skip to main content

Table 1 Characteristics of study groups

From: Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model

Group

Primary (1st, 2nd) vaccine

Booster vaccine

Negative control

Saline

Saline

Positive control

DTaP from GC pharma

Commercially available Tdap

GC3111

DTaP from GC pharma

GC3111 Tdap produced in 2010

Enhanced GC3111

DTaP from GC pharma

GC3111 Tdap FHA enhanced

  1. DTaP = diphtheria-tetanus-acellular pertussis, GC Pharma = Green Cross Pharma, Tdap = tetanus-reduced dose diphtheria-acellular pertussis, FHA = filamentous hemagglutinin
Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us